Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.53 | N/A |
| PEG Ratio (TTM) | -3.09 | N/A |
| P/S Ratio (TTM) | 0.32 | N/A |
| P/B Ratio (TTM) | 0.82 | N/A |
| P/FCF Ratio (TTM) | 9.22 | N/A |
| Price to 5YR AVG Earnings Ratio | 24.23 | N/A |
| Price to 5YR AVG FCF Ratio | 27.83 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.32% | N/A |
| ROE (TTM) | 8.04% | N/A |
| Net Profit Margin (TTM) | 2.93% | N/A |
| ROIC 5YR AVG | 5.19% | N/A |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 110.77% | 154.69% | 122.37% |
| Revenue | 1.28% | -0.58% | 3.27% |
| Net Income | 112.29% | 156.57% | 123.84% |
| Cash Flow | 1,619.06% | -15.71% | -5.78% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.18 | N/A |
| Quick Ratio (TTM) | 1.48 | N/A |
| D/E Ratio (TTM) | 0.06 | N/A |
| Interest Coverage (TTM) | 17.20 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.83 | N/A |
| LTL to 5YR AVG FCF | 2.12 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.58% | N/A |